New insights into PTSD’s genetic architecture unveiled by Dr. Kerry Ressler

In a comprehensive Genomic Press Interview, Dr. Kerry Ressler, Chief Scientific Officer at McLean Hospital and Professor of Psychiatry at Harvard Medical School, unveils groundbreaking advances in understanding the neurobiological basis of post-traumatic stress disorder (PTSD) and related anxiety conditions.

Zealand drug hit with CRL for ultra-rare disease amid manufacturing concerns, plans to resubmit in 2024

The FDA rejected Zealand Pharma’s glucagon receptor agonist in congenital hyperinsulinism (CHI) after identifying problems at a third-party manufacturing site. The company said it remains

December 29, 2023

Tailoring polymeric micelles for improved olaparib solubility and drug release

Olaparib is a selective poly (ADP-ribose) polymerase inhibitor. However, its clinical application is hindered by low solubility and undesired pharmacokinetic profiles (e.g., relatively short circulation).

May 23, 2024

CDC Reports Deaths After Medical Tourism in the Dominican Republic

There were 93 deaths among U.S. residents who traveled to the Dominican Republic (D.R.) for cosmetic surgery from 2009 through 2022, according to findings in

January 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.